Metastasis-directed radiation therapy plus hormone therapy...
Researchers from The University of Texas MD Anderson Cancer Center demonstrated that adding metastasis-directed radiation therapy to...
MD Anderson’s Guillermina Lozano receives AAMC Award for...
In recognition of her trailblazing work uncovering the mechanisms of the p53 tumor suppressor, Guillermina “Gigi” Lozano, Ph.D., chair...
Neoadjuvant immunotherapy with relatlimab and nivolumab is...
Giving the combination of immune checkpoint inhibitors relatlimab and nivolumab to patients with stage III melanoma before surgery was...
Some breast cancer patients with high responses to chemotherapy...
Patients with early-stage breast cancer who had a pathologic complete response (pCR) to neoadjuvant chemotherapy may be able to skip...
Response-adapted ultra-low dose radiation achieves complete...
Using a novel response-adapted ultra-low dose radiation therapy strategy, researchers at The University of Texas MD Anderson Cancer...
Allison Institute establishes internal advisory council of...
The James P. Allison Institute™ at The University of Texas MD Anderson Cancer Center today announced the establishment of its internal...
MD Anderson and WHO establish new international...
The University of Texas MD Anderson Cancer Center and World Health Organization (WHO) today announced a formal agreement to establish...
MD Anderson Research Highlights for October 19, 2022
The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recent basic, translational and...
MD Anderson hosts Leading Edge of Cancer Research Symposium
The University of Texas MD Anderson Cancer Center will host its virtual Leading Edge of Cancer Research Symposium from November 17-18,...
Lung, breast and colorectal cancer tackled in latest Texas...
Three new cancer research projects have been chosen to receive seed funding as part of the program in Oncological Data and...
MD Anderson and ARTIDIS announce strategic alliance to...
The University of Texas MD Anderson Cancer Center and ARTIDIS AG today announced a strategic alliance to investigate ARTIDIS...